Schlagwort: Generate Biomedicines
Veraxa: BiTAC, Börsengang, Bewährungsprobe
Ab dem 11. Juni wird die Aktie der VERAXA Biotech AG unter dem Kürzel VRXA (ISIN CH1476899161, WKN A4205C) an der Nasdaq gehandelt, die...
AI in Drug Development: Where Value is Emerging
The pharmaceutical industry is defined by well-known metrics: decade-long development timelines, billion-dollar costs, high failure rates. Against this backdrop, AI promises to make drug...